Articles
Recombinant factor VIIa versus placebo for spontaneous intracerebral haemorrhage within 2 h of symptom onset (FASTEST): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial
Joseph P Broderick, Andrew M Naidech, Jordan J Elm, et al
Lancet Available online 4 February 2026
https://doi.org/10.1016/S0140-6736(26)00097-8
Summary
Background
Recombinant factor VIIa has been shown to slow bleeding in patients ...
阅读全文